Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

NCT: NCT02928497 · TERMINATED

NCT IDNCT02928497
StatusTERMINATED
Start Date2017-02-06
Completion2025-09-23
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to establish the safety and effectiveness of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen, for subjects with non-valvular atrial fibrillation who are deemed not to be eligible for anti-coagulation therapy to reduce the risk of stroke.

Frequently Asked Questions

What is Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation?

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation is a clinical trial registered under NCT02928497. Current status: TERMINATED.

What is the status of NCT02928497?

The current status of NCT02928497 (Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation) is: TERMINATED.

When did Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation start?

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation started on 2017-02-06.

Related Devices

PMA P130013System, appendage closure, left atrialBoston Scientific Corp K152231Hornet Guidewire, Hornet 10 Guidewire, Hornet 14 GuidewireBoston Scientific Corporation K152842WALLSTENT RP ENDOPROSTHESIS TRACHEOBRONCHIAL, WALLSTENT ENDOPROSTHESIS TRACHEOBRONCHIALBoston Scientific Corporation K153617OptiCross 6, 40 MHz Coronary Imaging Catheter (US Distribution), OptiCross 6, 40 MHz Coronary Imaging Catheter (EU Distribution), OptiCross 6, 40 MHz Coronary Imaging Catheter (Intercontinental Distribution)Boston Scientific Corporation K160173Ultra ICE Plus 9 MHz IntraCardiac Echo Catheter(eDFU), Ultra ICE Plus 9 MHz IntraCardiac Echo Catheter (Paper DFU)Boston Scientific Corporation

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑